Press release
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics - Top Companies Regional and Data Analysis here
News-ID: 3825669 • Views: …
More Releases from The Insight Partners
Electric Bug Zapper Market Technology and Innovation Trends
The Electric Bug Zapper Market is supported by growing public awareness of health and hygiene. Electric bug zappers offer insect control without introducing chemicals into living spaces. This benefit has increased adoption across residential and commercial applications.
Product innovation is focused on improved energy efficiency and user safety. The Electric Bug Zapper Market benefits from these advancements as consumers seek long lasting and cost effective solutions.
As pest control remains an ongoing…
Microbiome Therapeutics Market Accelerates with 10.1% CAGR Through 2030
The Microbiome Therapeutics Market is emerging as a transformative segment within the global healthcare and biotechnology landscape, driven by growing scientific evidence linking the human microbiome to overall health and disease management. According to industry insights, the microbiome therapeutics market size is expected to grow from US$ 375.92 million in 2022 to reach US$ 813.38 million by 2030, registering a strong compound annual growth rate (CAGR) of 10.1% during the…
Car Wash Accessories Market Forecast Highlights Future Demand
The Car Wash Accessories Market is gaining prominence as vehicle care becomes more mainstream. Drivers and automotive enthusiasts alike recognize that comprehensive cleaning requires more than traditional soap and water. Accessories designed to assist in effective washing, drying and detailing are gaining attention for their ability to safeguard vehicle surfaces. The market is evolving with companies offering solutions that cater to different levels of passion and expertise. Beginners are introduced…
Ethernet Test Equipment Market to Grow at 5.2% CAGR Through 2031, Driven by High …
The global Ethernet Test Equipment Market is poised for steady growth, projected to register a compound annual growth rate (CAGR) of 5.2% from 2025 to 2031, with market value expanding from US$ XX million in 2024 to US$ XX million by 2031, according to a new report by The Insight Partners. The growth is fueled by the rising adoption of high-speed Ethernet technologies, rapid expansion of data centers, and increasing…
More Releases for Pharmacogenomics
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
Pharmacogenomics Market Worth $13.16 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'Pharmacogenomics Market by Technology (PCR, Sequencing, Spectrometry, Electrophoresis), Application (Cancer, Cardiology, Neurology, Infectious Diseases), End User (Hospitals, Diagnostic Laboratories, Research Institutes)-Global Forecast to 2029.'
Download Free Research Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=5366
According to this latest publication from Meticulous Research®, the global pharmacogenomics market is projected to reach $13.16 billion by 2029, at a CAGR of 8.6% during the forecast period…
